Metabolic effects of bretylium and phentolamine in euthyroid and thyrotoxic rats.
D000313:Adrenal Medulla / Q000502:physiology; D000315:Adrenalectomy; D000818:Animals; D001949:Bretylium Compounds / Q000494:pharmacology*; D004336:Drug Antagonism; D005964:Glucosyltransferases / Q000378:metabolism*; D006439:Hemodynamics / Q000187:drug effects; D006980:Hyperthyroidism / Q000201:enzymology*; D008297:Male; D009206:Myocardium / Q000201:enzymology*; D010646:Phentolamine / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013268:Stimulation, Chemical; D013961:Thyroid Gland / Q000187:drug effects*; D013963:Thyroid Hormones / Q000494:pharmacology; D013974:Thyroxine / Q000494:pharmacology
D001949:Bretylium Compounds; D013963:Thyroid Hormones; D012110:Reserpine; D005964:Glucosyltransferases; D013974:Thyroxine; D010646:Phentolamine